Multivalent Aptamer‐Functionalized Single‐Strand RNA Origami as Effective, Target‐Specific Anticoagulants with Corresponding Reversal Agents
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multivalent Aptamer‐Functionalized Single‐Strand RNA Origami as Effective, Target‐Specific Anticoagulants with Corresponding Reversal Agents
Authors
Keywords
-
Journal
Advanced Healthcare Materials
Volume -, Issue -, Pages 2001826
Publisher
Wiley
Online
2021-04-22
DOI
10.1002/adhm.202001826
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Advances in Aptamer Discovery and Applications
- (2019) Yang Zhang et al. MOLECULES
- Genetically Encoded, Functional Single‐Strand RNA Origami: Anticoagulant
- (2019) Abhichart Krissanaprasit et al. ADVANCED MATERIALS
- DNA Nanoscaffold‐Assisted Selection of Femtomolar Bivalent Aptamers for Human α‐Thrombin with Potent Anticoagulant Activity
- (2019) Yu Zhou et al. CHEMBIOCHEM
- Out-of-Plane Aptamer Functionalization of RNA Three-Helix Tiles
- (2019) Aradhana Chopra et al. Nanomaterials
- In vivo production of RNA nanostructures via programmed folding of single-stranded RNAs
- (2018) Mo Li et al. Nature Communications
- Development of a genetically encodable FRET system using fluorescent RNA aptamers
- (2018) Mette D. E. Jepsen et al. Nature Communications
- Composing RNA Nanostructures from a Syntax of RNA Structural Modules
- (2017) Cody Geary et al. NANO LETTERS
- Single-stranded DNA and RNA origami
- (2017) Dongran Han et al. SCIENCE
- Analysis of aptamer discovery and technology
- (2017) Matthew R. Dunn et al. Nature Reviews Chemistry
- Programmed Switching of Single Polymer Conformation on DNA Origami
- (2016) Abhichart Krissanaprasit et al. ACS Nano
- Pre-existing anti-PEG antibodies are associated with severe immediate allergic reactions to pegnivacogin, a PEGylated aptamer
- (2016) Thomas J. Povsic et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Pre-existing anti–polyethylene glycol antibody linked to first-exposure allergic reactions to pegnivacogin, a PEGylated RNA aptamer
- (2016) Nancy J. Ganson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Aptamers as targeted therapeutics: current potential and challenges
- (2016) Jiehua Zhou et al. NATURE REVIEWS DRUG DISCOVERY
- Cellular Delivery of RNA Nanoparticles
- (2016) Lorena Parlea et al. ACS Combinatorial Science
- Modulation of the Coagulation Cascade Using AptamersSignificance
- (2015) Rebecca S. Woodruff et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Routing of individual polymers in designed patterns
- (2015) Jakob Bach Knudsen et al. Nature Nanotechnology
- Transcription yield of fully 2′-modified RNA can be increased by the addition of thermostabilizing mutations to T7 RNA polymerase mutants
- (2015) Adam J. Meyer et al. NUCLEIC ACIDS RESEARCH
- New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
- (2015) Agon Mekaj et al. Therapeutics and Clinical Risk Management
- Venous thrombosis
- (2015) Alisa S. Wolberg et al. Nature Reviews Disease Primers
- Toward Larger DNA Origami
- (2014) Alexandria N. Marchi et al. NANO LETTERS
- A single-stranded architecture for cotranscriptional folding of RNA nanostructures
- (2014) C. Geary et al. SCIENCE
- Inhibiting the intrinsic pathway of coagulation with a factor XII-targeting RNA aptamer
- (2013) R. S. Woodruff et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- A high affinity, antidote-controllable prothrombin and thrombin-binding RNA aptamer inhibits thrombin generation and thrombin activity
- (2012) K. M. BOMPIANI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Direct thrombin inhibitors
- (2011) Catherine J. Lee et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy
- (2011) R. Tonelli et al. CLINICAL CANCER RESEARCH
- Increased anticoagulant activity of thrombin-binding DNA aptamers by nanoscale organization on DNA nanostructures
- (2011) Abhijit Rangnekar et al. Nanomedicine-Nanotechnology Biology and Medicine
- Peptide Nucleic Acids (PNA) in Chemical Biology and Drug Discovery
- (2010) Peter E. Nielsen CHEMISTRY & BIODIVERSITY
- Development of aptamer therapeutics
- (2010) David HJ Bunka et al. CURRENT OPINION IN PHARMACOLOGY
- NUPACK: Analysis and design of nucleic acid systems
- (2010) Joseph N. Zadeh et al. JOURNAL OF COMPUTATIONAL CHEMISTRY
- Weave Tile Architecture Construction Strategy for DNA Nanotechnology
- (2010) Majken N. Hansen et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Aptamers as therapeutics
- (2010) Anthony D. Keefe et al. NATURE REVIEWS DRUG DISCOVERY
- An Anticoagulant RNA Aptamer That Inhibits Proteinase-Cofactor Interactions within Prothrombinase
- (2009) Sai K. Buddai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Self-assembly of DNA into nanoscale three-dimensional shapes
- (2009) Shawn M. Douglas et al. NATURE
- Self-assembly of a nanoscale DNA box with a controllable lid
- (2009) Ebbe S. Andersen et al. NATURE
- Phase 1b Randomized Study of Antidote-Controlled Modulation of Factor IXa Activity in Patients With Stable Coronary Artery Disease
- (2008) Mark Y. Chan et al. CIRCULATION
- SELEX with modified nucleotides
- (2008) Anthony D Keefe et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- A randomized, repeat-dose, pharmacodynamic and safety study of an antidote-controlled factor IXa inhibitor
- (2008) M. Y. CHAN et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Crystal structure of an RNA aptamer bound to thrombin
- (2008) S. B. Long et al. RNA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started